الجامعة المستنصرية / كلية الادارة والاقتصاد

Abstract

The new trends in Iraq’s economic policy by adopting the market mechanism in the economy after 2003, which necessitated the integration between the role of the state represented by the public sector and the role of the private sector in the process of economic and social development that depends on mobilizing the community’s potential for various economic sectors and civil society institutions in institutional organizations that undertake, establishing and operating projects after the separate economic sectors faced challenges and difficulties in achieving development goals at the targeted levels. Therefore, many developed and developing countries sought to create institutions that adopt participatory organizations in which the public and private sectors contribute to directing, managing and operating projects, developing and developing them in order to serve Its objectives are based on a participatory basis, good governance, transparent accountability and mutual benefit, as the relationship between the partnership parties is characterized by an integrative and substitutionary nature at the same time, with a dynamic nature that depends on the size, nature and importance of the role that each sector plays in the development process, according to the prevailing economic system, and its stages of development up to faster rates of economic and social development, and the pharmaceutical industry is one of the Industries that require increased spending on research and development programs to produce patents within the pharmaceutical preparation processes for a new product, as well as flexibility in dealing with these expenses and their impact on the level of pricing and marketing of the pharmaceutical product. Most economic studies go to the fact that spending on research may reach more than 10 % of the value of pharmaceutical sales to obtain a therapeutic product using advanced technology. In this regard, we find that there is a difference in the use of technology in the pharmaceutical industry in both developed and developing countries, as pharmaceutical technology in developed countries depends on training and innovation, while pharmaceutical technology depends in developing countries, including Iraq, on improving manufacturing methods and quality control only. The research has been strengthened by highlighting the pharmaceutical partnership approved by the State Company for the Pharmaceutical Industry / Samarra as a reformist factor in economic activity, as well as supporting and encouraging the private sector and activating its role by emphasizing on building partnerships between the public and private sectors in the pharmaceutical manufacturing sector, and giving way to foreign pharmaceutical companies , the pharmaceutical industry market needs foreign investment to obtain financing sources as well as modern technology according to the formulas of cooperation or concession or contribution to the establishment of new pharmaceutical factories. The research concluded that the research hypothesis is achieved to a large extent when activating the mechanisms of partnership between the public and private sectors on the ground.